Autologous hematopoietic stem cell transplant at experienced centers in the current era can include indefinite disease ...

The leading research and educational conference for multiple sclerosis healthcare professionals in North America, the Consortium of Multiple Sclerosis Centers (CMSC) 38th Annual Meeting, returns to ...

NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data from the ULTIMATE I & II Phase 3 trials and the ENHANCE Phase 3b trial ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in adults with relapsing forms of multiple sclerosis (RMS) at ...

(Barcelona, Spain, Thursday, 25 September 2025) New research presented today at the 41 st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025) reveals ...

Separately, Janssen, in partnership with the National Multiple Sclerosis Society (NMSS), recently conducted a global patient research survey to examine the impact of MS-related fatigue across social ...

TG Therapeutics will present data on BRIUMVI for relapsing multiple sclerosis at the ACTRIMS forum, February 27 – March 1, 2025. TG Therapeutics, Inc. announced the schedule for presentations on data ...

Peer-led education was found to have a greater impact on multiple sclerosis (MS) health literacy than lecture-based education, a recent study from Iran demonstrated. A study comparing education styles ...

Sign up for our newsletter to get the latest on the transformative forces shaping the global economy, delivered every Thursday.

DOVER – Join Wentworth-Douglass Hospital and Wentworth Health Partners Coastal Neurology Associates for a free virtual community lecture during Multiple Sclerosis Awareness Month. Multiple Sclerosis, ...

Poster Presentation Title: No Association between Decreases in Serum Immunoglobulin Levels and Serious Infections with Long-Term Ublituximab Treatment in Patients with Relapsing Multiple Sclerosis ...